Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Blueprint Medicines Corporation Stock Price (Quote) NASDAQ:BPMC
$78.00 ( 2.78% ) Friday, 14th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $74.75 | $111.78 | Friday, 14th Jan 2022 BPMC stock ended at $78.00. This is 2.78% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 4.76% from a day low at $74.75 to a day high of $78.31. |
| 90 days | $74.75 | $117.86 | |
| 52 weeks | $74.75 | $117.86 |
Historical Blueprint Medicines Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-14 | $75.52 | $78.31 | $74.75 | $78.00 | 911 906 |
| 2022-01-13 | $80.95 | $81.65 | $75.75 | $75.89 | 955 183 |
| 2022-01-12 | $85.00 | $85.78 | $81.38 | $81.50 | 728 027 |
| 2022-01-11 | $87.14 | $87.66 | $85.00 | $85.86 | 577 065 |
| 2022-01-10 | $90.12 | $92.19 | $85.32 | $87.22 | 580 324 |
| 2022-01-07 | $92.10 | $93.81 | $90.00 | $91.45 | 577 123 |
| 2022-01-06 | $93.40 | $95.89 | $91.29 | $93.24 | 707 000 |
| 2022-01-05 | $103.99 | $103.99 | $90.76 | $93.30 | 1 862 482 |
| 2022-01-04 | $109.65 | $109.65 | $105.99 | $107.00 | 358 170 |
| 2022-01-03 | $107.72 | $110.23 | $105.35 | $110.08 | 250 785 |
| 2021-12-31 | $109.85 | $111.68 | $106.11 | $107.11 | 410 218 |
| 2021-12-30 | $109.36 | $111.32 | $108.13 | $109.45 | 280 317 |
| 2021-12-29 | $108.35 | $110.75 | $107.75 | $109.36 | 188 544 |
| 2021-12-28 | $110.12 | $111.18 | $107.29 | $108.08 | 202 694 |
| 2021-12-27 | $110.74 | $111.18 | $107.47 | $110.34 | 183 769 |
| 2021-12-23 | $108.61 | $111.78 | $108.12 | $110.97 | 150 519 |
| 2021-12-22 | $106.33 | $110.14 | $104.30 | $108.64 | 265 330 |
| 2021-12-21 | $106.37 | $107.86 | $105.44 | $106.44 | 435 277 |
| 2021-12-20 | $101.29 | $106.86 | $100.01 | $105.79 | 383 750 |
| 2021-12-17 | $98.69 | $104.38 | $98.40 | $102.75 | 816 229 |
| 2021-12-16 | $104.35 | $105.37 | $98.97 | $99.68 | 472 249 |
| 2021-12-15 | $98.52 | $104.28 | $98.02 | $104.21 | 440 165 |
| 2021-12-14 | $98.64 | $102.06 | $97.73 | $98.87 | 391 923 |
| 2021-12-13 | $96.78 | $100.04 | $95.71 | $99.62 | 438 801 |
| 2021-12-10 | $95.70 | $99.00 | $95.57 | $96.90 | 490 475 |
| 2021-12-09 | $97.90 | $98.85 | $95.31 | $95.64 | 216 439 |
| 2021-12-08 | $96.47 | $98.79 | $95.17 | $98.72 | 365 466 |
| 2021-12-07 | $96.31 | $98.97 | $95.52 | $96.72 | 294 804 |
| 2021-12-06 | $94.25 | $95.94 | $91.73 | $95.41 | 412 777 |
| 2021-12-03 | $98.86 | $98.86 | $93.04 | $94.25 | 614 538 |
| 2021-12-02 | $95.31 | $99.43 | $95.03 | $98.51 | 361 646 |
| 2021-12-01 | $97.70 | $100.98 | $95.95 | $96.03 | 412 503 |
| 2021-11-30 | $97.57 | $98.11 | $94.28 | $96.20 | 561 945 |
| 2021-11-29 | $102.45 | $102.68 | $96.20 | $98.28 | 570 340 |
| 2021-11-26 | $102.74 | $103.52 | $99.36 | $100.85 | 264 356 |
| 2021-11-24 | $103.44 | $104.42 | $101.73 | $104.29 | 206 337 |
| 2021-11-23 | $107.14 | $107.74 | $101.55 | $103.88 | 441 833 |
| 2021-11-22 | $109.32 | $109.68 | $106.98 | $107.79 | 206 430 |
| 2021-11-19 | $110.30 | $111.00 | $108.61 | $108.92 | 187 046 |
| 2021-11-18 | $111.66 | $113.30 | $110.11 | $110.39 | 312 045 |
| 2021-11-17 | $114.55 | $114.87 | $110.67 | $111.99 | 291 949 |
| 2021-11-16 | $114.28 | $115.98 | $113.22 | $115.36 | 305 104 |
| 2021-11-15 | $115.49 | $115.49 | $112.14 | $115.16 | 234 262 |
| 2021-11-12 | $115.98 | $116.60 | $113.22 | $114.35 | 366 415 |
| 2021-11-11 | $114.12 | $116.12 | $113.96 | $115.99 | 282 287 |
| 2021-11-10 | $115.23 | $117.86 | $113.62 | $114.26 | 292 603 |
| 2021-11-09 | $113.89 | $115.84 | $112.50 | $114.95 | 356 967 |
| 2021-11-08 | $114.13 | $115.02 | $112.33 | $113.43 | 222 509 |
| 2021-11-05 | $112.35 | $116.11 | $111.19 | $114.50 | 479 728 |
| 2021-11-04 | $111.44 | $112.82 | $109.29 | $112.66 | 310 235 |
Blueprint Medicines Corporation, a biopharmaceutical company, develops drugs of small molecule kinase inhibitors that target genomic drivers in various cancers and rare genetic diseases. Its lead drug candidates include BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants for patients with systemic mastocytosis, a myeloproliferative disorder of the mast cells, and defined subsets of patie... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
